Update shared on08 Aug 2025
Fair value Increased 12%The consensus analyst price target for Vistra has increased to $207.22, primarily reflecting an improved net profit margin, despite a slight reduction in revenue growth forecasts.
What's in the News
- Vistra completed the repurchase of 1,705,797 shares for $273.13 million, totaling 163,499,236 shares (39.89% of shares outstanding) bought back for $5,350 million under its ongoing buyback program.
- The company reported unaudited impairments of long-lived assets totaling $68 million for the quarter ended June 30, 2025.
- Vistra increased its quarterly common stock dividend per share by approximately 3% to $0.2260, resulting in an estimated total payment of $75 million for the quarter.
- The Nuclear Regulatory Commission approved a 20-year license extension for Vistra’s 1,268-MW Perry Nuclear Power Plant through 2046, making all six of Vistra’s nuclear reactors licensed for 60-year operations and reinforcing the company’s position as a leading operator of competitive nuclear assets.
Valuation Changes
Summary of Valuation Changes for Vistra
- The Consensus Analyst Price Target has risen from $192.56 to $207.22.
- The Net Profit Margin for Vistra has risen from 12.74% to 13.52%.
- The Consensus Revenue Growth forecasts for Vistra has fallen from 9.5% per annum to 9.0% per annum.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.